Replies to post #86606 on $heff's $tation of $tocks & $olid DD

[Chimaera]

$ZGNX Brean Capital agrees, reiterated buy rating and $2.50 target today:

Brean Capital Reiterates Buy After Zogenix, Inc. Sells Painkiller

[north40000]

ZGNX is - today, CORT is + 16%. Any reconciliation, 3D? Or am I comparing apples and oranges? New indication for Corcept after trial failure for psychotic depression. Cf

http://seekingalpha.com/article/2978076-how-alan-leong-of-biowatch-news-keeps-successful-biotech-investing-simple